A quantitative structure-activity relationship (QSAR) is a computational or mathematical modeling approach to reveal connections between biological activities and chemical compounds’ structural properties. It attempts to correlate chemical structure with an activity using statistical approaches. The QSAR models are beneficial for various purposes, including the prediction of actions of untested chemicals. Also, it helps to prioritize desired biological activities as an in-silico methodology and thus decreases the number of candidate chemicals to be tested with in vivo experiments.
The quantitative structure-activity relationship (QSAR) market majorly consists of the players such Protoqsar Sl., Intertek Group Plc, Bibra Toxicology Advice And Consulting Ltd, Covance Inc. (Labcorp), Latham Biopharm Group, Nsf International, Creative Biolabs, Qsar Lab Sp. Z O, Dassault Systèmes among others. The companies have been implementing various strategies that have helped the growth of the company and in turn have brought about various changes in the market. The companies have adopted several inorganic and organic strategies to accelerate their growth and improve their market position.
Dassault Systèmes and Covance, Inc. – Notable Market Players in Quantitative Structure-Activity Relationship (QSAR) Market
Global quantitative structure-activity relationship (QSAR) market is segmented by region into North America, Europe, Asia Pacific, Middle East &Africa and South & Central America. The North American region is the largest shareholder and the Asia Pacific is the fastest growing market for quantitative structure-activity relationship (QSAR). The growth of the North America market is attributed to growing adoption ate of the artificial intelligence technologies in the pharmaceutical industries of the region. Additionally, Canada’s Centre for Drug Research and Development has been working to grow and accelerate Canadian-based research, and has spun out seven companies that aim to solve unmet medical needs.
